Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated <it>falciparum</it> malaria in calabar, Nigeria
<p>Abstract</p> <p>Background</p> <p>The use of anti-malarial drug combinations with artemisinin, or with one of its derivatives, is now widely recommended to overcome drug resistance in falciparum malaria. Fixed-dose combination of artemisinin and naphthoquine is a new...
Main Authors: | Meremikwu Martin M, Odey Friday, Oringanje Chioma, Oyo-ita Angela, Effa Emmanuel, Esu Ekpereonne B, Eyam Eyam, Oduwole Olabisi, Asiegbu Vivian, Alaribe Ambrose, Ezedinachi Emmanuel N |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | http://www.malariajournal.com/content/11/1/413 |
Similar Items
-
Artemisinin-naphthoquine versus Artemether-lumefantrine for treating uncomplicated plasmodium falciparum malaria in children: A randomized controlled trial of efficacy and safety
by: Udoh E, et al.
Published: (2024-07-01) -
Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress
by: Qingyun Huang, et al.
Published: (2010-12-01) -
Efficacy and safety of artemisinin-naphthoquine <it>versus</it> dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia
by: Tjitra Emiliana, et al.
Published: (2012-06-01) -
Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
by: Brioni R. Moore, et al.
Published: (2017-10-01) -
Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trial
by: Hui Liu, et al.
Published: (2024-01-01)